S. Ratcliffe | Charles Explorer

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex (R)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

2011 | Publication without faculty affiliation